Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.46 |
| ▸ | PPARG | P37231 | 7/20 | 0.46 |
| ▸ | PPARD | Q03181 | 7/20 | 0.46 |
| ▸ | PPARA | Q07869 | 7/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.46 |
| ▸ | TSHR | P16473 | 5/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | TLR2 | O60603 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | FABP4 | P15090 | 2/20 | 0.46 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | PDE4A | P27815 | 1/20 | 0.46 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27654154 | 0.98 | AKR1B1 (0.46) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL27711950 | 0.93 | AKR1B1 (0.52) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL27667890 | 0.91 | GPR84 (0.54) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL21551890 | 0.91 | GPR84 (0.54) | AKR1B1GPR84PPARGPPARDPPARA | |
| Adipic Acid SCHEMBL10796241 | 0.87 | AKR1B1 (0.64) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL381779 | 0.81 | AKR1B1 (0.48) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL7450355 | 0.81 | MEN1 (0.38) | ALDH1A1MEN1KMT2ACYP1A2THRB | |
| SCHEMBL380377 | 0.79 | AKR1B1 (0.46) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL14360182 | 0.78 | AKR1B1 (0.50) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL6629710 | 0.78 | CAMK2A (0.48) | AKR1B1GPR84PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2049102-A2 | POLYMORPHIC FORMS OF AN HMG-COA REDUCTASE INHIBITOR AND USES THEREOF | RANBAXY LABORATORIES, LTD. (IN) | 2009-04-22 | — | — | EP | claimed |
| WO-2008010087-A2 | POLYMORPHIC FORMS OF AN HMG-COA REDUCTASE INHIBITOR AND USES THEREOF | RANBAXY LABORATORIES LIMITED (US) | 2008-01-24 | — | — | WO | claimed |
| CN-1980890-A | Process for the preparation of atorvastatin | RANBAXY LAB LTD (IN) | 2007-06-13 | — | — | CN | claimed |
| JP-2007500203-A | — | — | 2007-01-11 | — | — | JP | claimed |
| EP-1658283-A2 | SUBSTITUTED PYRROLE DERIVATIVES AND THEIR USE AS HMG-CO INHIBITORS | RANBAXY LABORATORIES, LTD. (IN) | 2006-05-24 | — | — | EP | claimed |
| EP-1643988-A1 | SUBSTITUTED PYRROLE DERIVATIVES AS HMG-COA REDUCTASE INHIBITORS | RANBAXY LABORATORIES, LTD. (IN) | 2006-04-12 | — | — | EP | claimed |
| WO-2004105752-A1 | SUBSTITUTED PYRROLE DERIVATIVES AS HMG-COA REDUCTASE INHIBITORS | RANBAXY LABORATORIES LIMITED (IN) | 2004-12-09 | — | — | WO | claimed |
| WO-2004106299-A2 | SUBSTITUTED PYRROLE DERIVATIVES AND THEIR USE AS HMG-CO INHIBITORS | RANBAXY LABORATORIES LIMITED (IN) | 2004-12-09 | — | — | WO | claimed |
| EP-1470106-A1 | METHOD OF MANUFACTURING AN AMORPHOUS FORM OF THE HEMI-CALCIUM SALT OF (3R, 5R) 7- 3-PHENYL-4-PHENYLCARBAMOYL-2-(4-FLUOROPHENYL)-5-ISOPROPYL-PYRROL-1-YL!-3, 5-DIHYDROXYHEPTANOIC ACID (ATORVASTATIN) | Zentiva, A.S. (CZ) | 2004-10-27 | — | — | EP | claimed |
| WO-2003068739-A1 | METHOD OF MANUFACTURING AN AMORPHOUS FORM OF THE HEMI-CALCIUM SALT OF (3R, 5R) 7- 3-PHENYL-4-PHENYLCARBAMOYL-2-(4-FLUOROPHENYL)-5-ISOPROPYL-PYRROL-1-YL!-3, 5-DIHYDROXYHEPTANOIC ACID (ATORVASTATIN) | ZENTIVA A.S. (CZ) | 2003-08-21 | — | — | WO | claimed |
| US-RE36520-E | ANTICHOLESTEROL AGENTS; TREATMENT OF ARTERIOSCLEROSIS, CARDIOVASCULAR DISORDERS | MERCK & CO., INC. (US) | 2000-01-18 | — | — | US | claimed |
| EP-0524190-A1 | HMG-CO A REDUCTIVE INHIBITORS | BRITISH BIO-TECHNOLOGY LIMITED (GB) | 1993-01-27 | — | — | EP | claimed |
| EP-0480986-A1 | 6-(HYDRONAPHTYL-1-ETHYL)-4-HYDROXY-3,4,5,6-TETRAHYDRO-2H-PYRAN-2-ONES AND THE CORRESPONDING HYDROXY ACIDS | BRITISH BIO-TECHNOLOGY LIMITED (GB) | 1992-04-22 | — | — | EP | claimed |
| WO-1991015482-A1 | HMG-CO A REDUCTIVE INHIBITORS | BRITISH BIO-TECHNOLOGY LIMITED (GB) | 1991-10-17 | — | — | WO | claimed |
| US-5049696-A | Enzyme inhibitors | MERCK & CO., INC. (US) | 1991-09-17 | — | — | US | claimed |
| US-5021453-A | 3-hydroxy-3-methyl glutaryl coenzyme a; anticholesterol-antilepemic agent | MERCK & CO., INC. (US) | 1991-06-04 | — | — | US | claimed |
| US-4937264-A | HYDROXYMETHYLGLUTARYL-COENZYME A REDUCTASE INHIBITORS | MERCK & CO., INC. (US) | 1990-06-26 | — | — | US | claimed |
| US-4937263-A | HYDROXYMETHYLGLUTARYL-COENZYME A REDUCTASE INHIBITORS | MERCK & CO., INC. (US) | 1990-06-26 | — | — | US | claimed |
| EP-3500309-A1 | STABLE ATORVASTATIN SUSPENSION COMPOSITION | Rosemont Pharmaceuticals Limited (GB) | 2019-06-26 | — | — | EP | disclosed |
| US-4857546-A | ANTICHOLESTEROL, ANTILIPEMIC AGENTS | MERCK & CO., INC. (US) | 1989-08-15 | — | — | US | disclosed |